News und Analysen

The biopharmaceuticals space is notorious for sudden, sharp rallies, and for precipitous sell-offs as well. The industry is crowded with names, many of which are tiny firms working toward

Short squeezes, a market condition where quickly exiting short sellers cause stock prices to rise sharply, can lead to substantial gains for traders and investors. The problem is that a high short

AutoNation’s (NYSE: AN) stock recently touched a new 52-week high, a milestone that often signals a company’s value is fully recognized by the market. For many investors, a peak price might

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough time attracting investment capital in 2024. Small- and mid-cap biotech

On June 24, Nektar Therapeutics (NASDAQ: NKTR) stock exploded nearly 157% following news that Rezpeg, the company’s experimental treatment for atopic dermatitis (eczema), successfully met its

The S&P 500 made a new all-time high this week. The move was supported by several factors, such as a ceasefire between Israel and Iran, the announcement of a trade deal with China, and a reading on

Jared Woodard, Head of the Research Investment Committee at Bank of America Securities, argues that stock splits can be very positive for shares. Woodard’s research found that in the 52 weeks